Back
Autolus Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
51
AUTL
Autolus Therapeutics PLC
Last Price:
3.30
Seasonality Move:
-10.83%
Sell
15
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.77
Seasonality Move:
35.83%
Buy
51
Autolus Therapeutics PLC (AUTL)
is a Buy
Is Autolus Therapeutics PLC a Buy, Sell or Hold?
- The current Autolus Therapeutics PLC [AUTL] share price is $3.33. The Score for AUTL is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- AUTL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.79. The Score for ADAP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AUTL Stock Price Chart
What is Autolus Therapeutics PLC's stock price today?
-
The Autolus Therapeutics PLC share price today is $3.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.
AUTL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 38.58 | Sell |
| Chaikin Money Flow: | -2617533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.6 - 4.48) | Sell |
| Bollinger Bands (100): | (3.6 - 4.34) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 44.49 | Sell |
| Chaikin Money Flow: | 908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.75 - 0.87) | Sell |
| Bollinger Bands (100): | (0.85 - 1.21) | Sell |
AUTL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.55 | Sell |
| 20-day SMA: | 4.03 | Sell |
| 50-day SMA: | 3.95 | Sell |
| 200-day SMA: | 4.56 | Sell |
| 8-day EMA: | 3.62 | Sell |
| 20-day EMA: | 3.83 | Sell |
| 50-day EMA: | 3.94 | Sell |
| 200-day EMA: | 4.16 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.81 | Sell |
| 20-day SMA: | 0.79 | Buy |
| 50-day SMA: | 0.91 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.8 | Sell |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.89 | Sell |
| 200-day EMA: | 1.02 | Sell |
Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.25 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Autolus Therapeutics PLC Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||